Loss of LIMCH1 predicts poor prognosis in patients with surgically resected Lung Adenocarcinoma: A study based on Immunohistochemical Analysis and Bioinformatics

Background: LIMCH1, a novel actin-binding protein, is reported to correlate with tumorigenesis in multiple cancer types, but its clinical prognostic value in lung adenocarcinoma (LUAD) patients remains unclear. Methods: A total of 196 patients with LUAD who underwent R0 resection were included for a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, He, Zhao, Jing, Chen, Zhen, Sun, Wenjia, Ruan, Kexin, Zhou, Jianya, Zhou, Jianying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738819/
https://www.ncbi.nlm.nih.gov/pubmed/33391414
http://dx.doi.org/10.7150/jca.47883

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738819/
https://www.ncbi.nlm.nih.gov/pubmed/33391414
http://dx.doi.org/10.7150/jca.47883

Ejemplares similares